| Basics |
Quidel Corporation
Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It includes applications in infectious diseases, women's health, gastrointestinal diseases, and others.
|
| IPO Date: |
February 1, 1991 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$2.11B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.92 | 1.98%
|
| Avg Daily Range (30 D): |
$0.88 | 2.95%
|
| Avg Daily Range (90 D): |
$0.91 | 2.72%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.38M |
| Avg Daily Volume (30 D): |
1.48M |
| Avg Daily Volume (90 D): |
1.05M |
| Trade Size |
| Avg Trade Size (Sh.): |
78 |
| Avg Trade Size (Sh.) (30 D): |
59 |
| Avg Trade Size (Sh.) (90 D): |
55 |
| Institutional Trades |
| Total Inst.Trades: |
5,330 |
| Avg Inst. Trade: |
$3.3M |
| Avg Inst. Trade (30 D): |
$3.58M |
| Avg Inst. Trade (90 D): |
$3.13M |
| Avg Inst. Trade Volume: |
.05M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.29M |
| Avg Closing Trade (30 D): |
$6.91M |
| Avg Closing Trade (90 D): |
$5.61M |
| Avg Closing Volume: |
67.21K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-5.31
|
$-.19
|
$-2.62
|
|
Diluted EPS
|
$-5.31
|
$-.19
|
$-2.62
|
|
Revenue
|
$ 2.76B
|
$ 692.8M
|
$ 707.8M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -358.7M
|
$ -12.7M
|
$ -178.4M
|
|
Operating Income / Loss
|
$ -170.3M
|
$ 32.6M
|
$ -100.4M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 48.2M
|
$ 28.7M
|
$ -45.5M
|
|
PE Ratio
|
|
|
|
|
